A new catalyst promotes an asymmetric radical reaction using an engineered ligand that can differentiate between very similar ...

Scientists identify enzyme SIRT2 as key trigger of memory loss and brain inflammation in Alzheimer’s breakthrough.

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced the company will present data on its ...